Archives
-
EZ Cap™ Cas9 mRNA: Spatial CRISPR Design
2026-09-28
EZ Cap™ Cas9 mRNA (m1Ψ) supports controlled CRISPR-Cas9 genome editing in mammalian cells. This article presents a region-aware strategy for connecting Cas9 editing with transcriptomic analysis, using CD52-deficient male reproductive tissues as a model for better assay design.
-
Clozapine Workflows for Schizophrenia Research
2026-09-28
Use Clozapine to connect receptor pharmacology, prefrontal ERK1/2 readouts, and liver-safety controls in schizophrenia research. This workflow also shows how to use it as a carefully bounded pharmacological comparator—not a substitute for targeted magnetic stimulation studies of GABRE.
-
Syringin and Sunitinib in Renal Cell Carcinoma
2026-09-27
A 2024 study reports that Syringin suppresses renal cell carcinoma cell growth and migration, promotes apoptosis, and increases in vitro sensitivity to sunitinib. By combining network pharmacology, molecular docking, cell-based assays, and pathway analysis, the researchers implicate EGFR/PI3K/Akt signaling while leaving clinical efficacy and the mechanism of drug sensitization to be tested.
-
Quercetin Beyond the Pathway: Translational Strategy
2026-09-26
Quercetin offers translational researchers a useful way to interrogate kinase signaling, cell-death mechanisms, and inflammatory biology—provided its broad pharmacology is matched with careful controls. This article connects cancer-research mechanisms with preclinical neuroinflammation findings and outlines practical steps for designing interpretable experiments without overstating clinical relevance.
-
KPT330 Tunes Cas9 Precision Through mRNA Export
2026-09-25
The study identifies selective inhibitors of nuclear export, including KPT330, as indirect modulators of Cas9 activity: they interfere with Cas9 mRNA export rather than directly inhibiting the nuclease. In human cells, this approach improved the reported specificity of genome and base editing, while also inhibiting prime editing, and highlights mRNA trafficking as a potential control point for CRISPR systems.
-
VX-661: A Practical F508del CFTR Corrector Workflow
2026-09-25
Build a trafficking-first assay around VX-661, then separate rescued surface expression from channel function to see where the response is gained or lost. A benchmark treatment and calnexin-aware experimental design help make F508del CFTR results more interpretable across models.
-
EZ Cap™ Cas9 mRNA (m1Ψ) for Zygote Editing
2026-09-24
Pair capped, modified Cas9 mRNA with a guide RNA to build a transient CRISPR-Cas9 genome-editing workflow, including electroporation-based delivery to mouse zygotes. The article separates published electroporation benchmarks from product-handling guidance and highlights the controls needed to optimize editing without overlooking embryo viability.
-
Autophagy–Metastasis Signature in Colorectal Cancer
2026-09-24
Bai et al. developed a six-gene prognostic signature connecting autophagy and liver-metastasis-associated expression patterns with colorectal cancer outcomes, then examined its relationship to immune-cell states and treatment-response predictions. The integrated bulk and single-cell analyses suggest an immunosuppressive, potentially immunotherapy-resistant high-risk phenotype, while leaving clinical validation and causal testing as important next steps.
-
PPARα Suppresses Pyroptosis in LCA Liver Injury
2026-09-23
A 2026 study reports that PPARα activation attenuates lithocholic acid-induced cholestatic liver injury while suppressing two pyroptosis-associated pathways: NLRP3 signaling and APAF1/CASPASE-3/GSDME signaling. The findings connect nuclear-receptor activity with inflammatory cell-death mechanisms and provide a rationale for testing PPARα agonism in cholestatic liver models, while leaving clinical relevance and pathway causality to be established.
-
Septin4, VHL, and HIF-1α in Hypoxic Cardiomyocytes
2026-09-23
The reference study identifies Septin4 as a previously unrecognized aggravator of hypoxia-induced cardiomyocyte injury. Its data support a mechanism in which Septin4 binds HIF-1α and promotes VHL-dependent ubiquitination and proteasomal degradation, weakening an adaptive response to oxygen deprivation.
-
Electroporation for CRISPR Editing in Mouse Zygotes
2026-09-22
Hashimoto and Takemoto showed that electroporation can deliver CRISPR/Cas9 RNA into mouse zygotes with an intact zona pellucida, providing a scalable alternative to embryo microinjection. Their optimized pulse conditions supported both nuclease-mediated mutation and ssODN-directed knock-in, although the findings remain specific to early mouse embryos and require careful optimization in other systems.
-
Staurosporine A8192: Reliable Apoptosis Assays
2026-09-22
This scenario-based guide explains how Staurosporine (SKU A8192) can support reproducible apoptosis, viability, and kinase-signaling experiments while addressing solubility, dosing, and interpretation challenges. It connects product-specific handling data with practical controls and literature-based guidance for separating cell death from assay artifacts.
-
Palonosetron hydrochloride in 5-HT3 Assays
2026-09-21
Palonosetron hydrochloride supports precise nanomolar 5-HT3A and 5-HT3AB receptor studies, while its micromolar activity enables a separate OCT2 and MATE1 renal transporter workflow. This guide translates pharmacology into practical cell-based assays, controls, troubleshooting steps, and cancer research applications.
-
DPPH Workflow for In Vitro Antioxidant Screening
2026-09-21
DPPH provides a fast, plate-compatible way to rank purified compounds, extracts, and cultivation conditions by radical-scavenging activity. This workflow pairs fresh reagent preparation and matrix controls with orthogonal profiling, helping researchers distinguish useful antioxidant hits from color or solubility artifacts.
-
Cas9 mRNA Design for Translational Editing
2026-09-20
A mechanistic and strategic guide to using Cap1-capped, m1Ψ-modified Cas9 mRNA for reproducible CRISPR-Cas9 genome editing in mammalian systems, with evidence-based lessons from electroporation in mouse zygotes.